Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
7.09
-0.53 (-6.96%)
At close: Dec 5, 2025, 4:00 PM EST
7.09
0.00 (0.00%)
After-hours: Dec 5, 2025, 5:01 PM EST
Bioventus Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Bioventus stock ranges from a low of $12 to a high of $15. The average analyst price target of $13.33 forecasts a 88.01% increase in the stock price over the next year.
Price Target: $13.33 (+88.01%)
Analyst Consensus: Buy
* Price targets were last updated on Jul 7, 2025.
Analyst Ratings
The average analyst rating for Bioventus stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $12 | Buy | Initiates | $12 | +69.25% | Jul 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +111.57% | Mar 17, 2025 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $12 → $13 | Sell → Hold | Upgrades | $12 → $13 | +83.36% | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $15 | Strong Buy | Maintains | $12 → $15 | +111.57% | Nov 6, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $17 | Strong Buy | Maintains | $12 → $17 | +139.77% | Sep 27, 2024 |
Financial Forecast
Revenue This Year
572.45M
from 573.28M
Decreased by -0.14%
Revenue Next Year
613.16M
from 572.45M
Increased by 7.11%
EPS This Year
0.67
from -0.52
EPS Next Year
0.82
from 0.67
Increased by 22.73%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 596.9M | 645.6M | |
| Avg | 572.5M | 613.2M | |
| Low | 553.4M | 588.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 4.1% | 12.8% | |
| Avg | -0.1% | 7.1% | |
| Low | -3.5% | 2.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.70 | 0.89 | |
| Avg | 0.67 | 0.82 | |
| Low | 0.64 | 0.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 33.9% | |
| Avg | - | 22.7% | |
| Low | - | 13.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.